Kodiak Sciences Inc (FRA:K27)
€ 3.514 -0.152 (-4.15%) Market Cap: 185.77 Mil Enterprise Value: -3.95 Mil PE Ratio: 0 PB Ratio: 0.75 GF Score: 37/100

Kodiak Sciences Inc at UBS Global Healthcare Virtual Conference Transcript

May 25, 2021 / 07:00PM GMT
Release Date Price: €67.5 (+3.85%)
Esther P. Rajavelu
UBS Investment Bank, Research Division - Analyst & Executive Director

Good afternoon, everyone. I hope you all joining the virtual conference here at UBS. And I -- and I'm exited to host this fireside chat with the Kodiak management team. And I'm joined here by Victor Perlroth, CEO; John Borgeson, CFO; Jason, Ehrlich, as Chief Medical Officer; and John Kim, who is the Director or of Corporate Development. Welcome, gentlemen, and thank you for your time today.

Victor Perlroth
Kodiak Sciences Inc. - Chairman, MD, CEO & President

Thanks a lot, Esther. We're very pleased us to be at the conference and to participate and to share a little bit of the Kodiak story and our progress.

Esther P. Rajavelu
UBS Investment Bank, Research Division - Analyst & Executive Director

Great. Sounds great. So why don't we maybe, Victor, if you could just give us an update on where things are? We've had your press release with the quarterly update, and just kind of want things stand on the clinical front,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot